GH-axis / body composition
CJC-1295 + Ipamorelin
CJC-1295 and ipamorelin each have human endocrine/PK evidence, but that does not establish additive benefit, an optimal ratio or long-term safety for the combination.
Exact-combination evidence
Community-popular combination; component evidence only
CJC-1295 and ipamorelin each have human endocrine/PK evidence, but that does not establish additive benefit, an optimal ratio or long-term safety for the combination.
Human combination evidence
No direct controlled human combination trial identified in current evidence set
Combination safety
No validated combination safety framework
How to read this combination page
Component evidence and direct combination evidence are kept separate. Study doses or regimens, where mentioned, describe the cited research only and are not recommendations for personal use.